Given the well-established role of inflammatory mechanisms in CAD pathogenesis, coupled with the role of IL-6 as a pro-inflammatory cytokine, it is tempting to speculate that induction of inflammation mediated by altered IL-6 levels regulated by specific IL-6 variants may modulate CAD development and progression. Here, IL6 is linked to coronary artery disorder.